Casdin Capital, LLC Relay Therapeutics, Inc. Transaction History

Casdin Capital, LLC

$1.16 Billion
Q4 2024

A detailed history of Casdin Capital, LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Casdin Capital, LLC holds 8,948,574 shares of RLAY stock, worth $37.2 Million. This represents 3.17% of its overall portfolio holdings.

Number of Shares

8,948,574

Previous 9,251,108 3.27%

Holding current value

$37.2 Million

Previous $65.5 Million 43.71%

% of portfolio

3.17%

Previous 5.09%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$4.12 - $6.8 $1.25 Million - $2.06 Million	-302,534 Reduced 3.27%	8,948,574 $36.9 Million
Q3 2024 Nov 14, 2024	BUY	$6.23 - $9.51 $5 Million - $7.63 Million	802,534 Added 9.5%	9,251,108 $65.5 Million
Q2 2024 Aug 14, 2024	BUY	$5.9 - $8.02 $6.05 Million - $8.22 Million	1,025,000 Added 13.81%	8,448,574 $55.1 Million
Q1 2024 May 15, 2024	BUY	$7.5 - $12.07 $267,232 - $430,066	35,631 Added 0.48%	7,423,574 $61.6 Million
Q4 2023 Feb 14, 2024	BUY	$6.01 - $11.48 $2.79 Million - $5.33 Million	464,369 Added 6.71%	7,387,943 $81.3 Million
Q3 2023 Nov 14, 2023	BUY	$8.24 - $12.97 $7.62 Million - $12 Million	925,000 Added 15.42%	6,923,574 $58.2 Million
Q2 2023 Aug 14, 2023	BUY	$9.99 - $18.27 $3 Million - $5.48 Million	300,000 Added 5.26%	5,998,574 $75.3 Million
Q1 2023 May 15, 2023	BUY	$15.0 - $22.76 $40 Million - $60.7 Million	2,667,926 Added 88.03%	5,698,574 $93.9 Million
Q4 2022 Feb 14, 2023	SELL	$14.16 - $24.02 $23.4 Million - $39.7 Million	-1,652,784 Reduced 35.29%	3,030,648 $45.3 Million
Q3 2022 Nov 14, 2022	BUY	$18.07 - $31.37 $11.1 Million - $19.3 Million	614,858 Added 15.11%	4,683,432 $105 Million
Q2 2022 Aug 15, 2022	BUY	$13.31 - $34.88 $2.81 Million - $7.37 Million	211,321 Added 5.48%	4,068,574 $68.1 Million
Q4 2021 Feb 14, 2022	BUY	$26.0 - $37.03 $4.91 Million - $6.99 Million	188,679 Added 5.14%	3,857,253 $118 Million
Q3 2021 Nov 15, 2021	BUY	$29.75 - $37.99 $8.73 Million - $11.2 Million	293,516 Added 8.7%	3,668,574 $116 Million
Q1 2021 May 17, 2021	SELL	$32.52 - $61.53 $14.1 Million - $26.7 Million	-433,836 Reduced 11.39%	3,375,058 $117 Million
Q3 2020 Nov 16, 2020	BUY	$32.81 - $45.1 $125 Million - $172 Million	3,808,894 New	3,808,894 $162 Million

Others Institutions Holding RLAY

# of Institutions

207

Shares Held

159M

Call Options Held

100K

Put Options Held

26.8K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $500M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Casdin Capital, LLC with notifications on news.

Account

Casdin Capital, LLC Relay Therapeutics, Inc. Transaction History